---
title: "Cell-type-specific genomic signatures and therapeutic targets in early Alzheimer’s disease"
id: "medrxiv-16-integrated-genomic-meta-analysis-identifies-cell-type-specific-signatures-and"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-16-integrated-genomic-meta-analysis-identifies-cell-type-specific-signatures-and"
content_type: "clinical_feed_article"
specialty: "Neurology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.21.26362150v1?rss=1"
published_at: "2026-09-23T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Cell-type-specific genomic signatures and therapeutic targets in early Alzheimer’s disease
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-16-integrated-genomic-meta-analysis-identifies-cell-type-specific-signatures-and
- **Specialty:** [Neurology](https://medichelpline.com/clinical-feed/neurology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.21.26362150v1?rss=1)
- **Published At:** 2026-09-23T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The authors performed a systematic review of publicly available datasets profiling **cell-type-specific** changes in early Alzheimer's disease (AD) and integrated findings across studies. - Multiomic results were combined using Meta-Analysis by Information Content (**MAIC**), a computational integration method designed to prioritise convergent genomic signals from diverse experimental sources. - Integration highlighted **electron transport chain** dysfunction in **mitochondria** as a shared pathway across neurons, microglia, and astrocytes in early AD. - **Wnt signalling** emerged as a prominent, astrocyte-specific signature in the integrated analysis. - The study identified pathological neuro‑glial signalling pairs such as **APP-CD74**, **APOE-SORL1**, and **WNT-FZD/LRP6** as candidate mechanisms relevant to early disease. - Cross-referencing integrated genomic signals with pharmacological data highlighted agents already investigated in AD (for example, **guanfacine**) and candidate repurposing compounds not previously prioritised, including **eltrombopag** and **encorafenib**. - The authors emphasise that the work is a systematic, integrative prioritisation of pathways and repurposing candidates intended to guide further investigation; the report is a preprint and has not been peer reviewed. - All data used were from openly available human and rodent datasets cited in the manuscript; data produced in the work are contained in the manuscript and supplementary materials. - The study declares no competing interests and reports funder support from multiple UK research organisations; ethical approvals and participant consent statements are addressed given the use of public datasets.
## Clinical Analysis & Structured Key Points
Integrated genomic meta-analysis identifies cell-type-specific signatures and targets in early Alzheimer's disease | medRxiv Skip to main content Integrated genomic meta-analysis identifies cell-type-specific signatures and targets in early Alzheimer's disease View ORCID Profile Moritz Steinruecke , View ORCID Profile J Kenneth Baillie , View ORCID Profile Zoeb Jiwaji doi: https://doi.org/10.64898/2026.09.21.26362150 Moritz Steinruecke 1 School of Clinical Medicine, University of Cambridge; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Moritz Steinruecke J Kenneth Baillie 2 Roslin Institute, The University of Edinburgh; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for J Kenneth Baillie Zoeb Jiwaji 3 UK Dementia Research Institute at the University of Edinburgh Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Zoeb Jiwaji For correspondence: zoeb.jiwaji{at}ed.ac.uk Abstract Info/History Metrics Supplementary material Data/Code Preview PDF Abstract Cellular mechanisms in early Alzheimer's disease (AD) remain poorly understood despite generation of extensive observational multiomic data. Weighted integration across diverse datasets can prioritise convergent mechanisms and targets. We conducted a systematic review to identify datasets profiling cell-type-specific changes in early AD. We integrated multiomic findings using Meta-Analysis by Information Content (MAIC), a computational method which combines genomic data from diverse experimental sources. Electron transport chain dysfunction in mitochondria emerged as a shared pathway in neurons, microglia, and astrocytes, and Wnt signalling was a prominent astrocyte-specific signature. Pathological neuro-glial signalling mechanisms included APP-CD74, APOE-SORL1, and WNT-FZD/LRP6. Integration with pharmacological data identified therapeutics already under investigation in AD, such as guanfacine, and candidates not previously prioritised, such as eltrombopag and encorafenib. We present a systematic analysis of cell-type-specific changes in early AD to prioritise pathways for investigation and therapeutics for repurposing. Competing Interest Statement The authors have declared no competing interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The study used only openly available human and rodent datasets. All sources of these datasets are cited in the manuscript (Table 1). I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability All data produced in the present work are contained in the manuscript and supplementary materials. Funder Information Declared Wellcome Trust, https://ror.org/029chgv08 , 223164/Z/21/Z UK Research and Innovation , MR/Y030877/1 , MC_PC_20004 , MC_PC_19025 , MC_PC_1905 , MRNO2995X/1 , MC_PC_20029 Sepsis Research Biotechnology and Biological Sciences Research Council , BB/P013732/1 , BB/P013759/1 Chief Scientist Office , NRS/M/26/99 UK Dementia Research Institute, https://ror.org/02wedp412 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license . Back to top Previous Next Posted September 23, 2026. Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Integrated genomic meta-analysis identifies cell-type-specific signatures and targets in early Alzheimer's disease Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Integrated genomic meta-analysis identifies cell-type-specific signatures and targets in early Alzheimer's disease Moritz Steinruecke , J Kenneth Baillie , Zoeb Jiwaji medRxiv 2026.09.21.26362150; doi: https://doi.org/10.64898/2026.09.21.26362150 Share This Article: Copy Citation Tools Integrated genomic meta-analysis identifies cell-type-specific signatures and targets in early Alzheimer's disease Moritz Steinruecke , J Kenneth Baillie , Zoeb Jiwaji medRxiv 2026.09.21.26362150; doi: https://doi.org/10.64898/2026.09.21.26362150 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Areas All Articles Addiction Medicine (619) Allergy and Immunology (906) Anesthesia (336) Cardiovascular Medicine (4840) Dentistry and Oral Medicine (479) Dermatology (419) Emergency Medicine (653) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1635) Epidemiology (15989) Forensic Medicine (33) Gastroenterology (1206) Genetic and Genomic Medicine (7073) Geriatric Medicine (734) Health Economics (1067) Health Informatics (5076) Health Policy (1438) Health Systems and Quality Improvement (1780) Hematology (587) HIV/AIDS (1347) Infectious Diseases (except HIV/AIDS) (16317) Intensive Care and Critical Care Medicine (1177) Medical Education (675) Medical Ethics (156) Nephrology (727) Neurology (7321) Nursing (370) Nutrition (1089) Obstetrics and Gynecology (1246) Occupational and Environmental Health (1007) Oncology (3626) Ophthalmology (1058) Orthopedics (398) Otolaryngology (458) Pain Medicine (478) Palliative Medicine (140) Pathology (709) Pediatrics (1807) Pharmacology and Therapeutics (739) Primary Care Research (769) Psychiatry and Clinical Psychology (5930) Public and Global Health (9785) Radiology and Imaging (2439) Rehabilitation Medicine and Physical Therapy (1457) Respiratory Medicine (1251) Rheumatology (644) Sexual and Reproductive Health (775) Sports Medicine (583) Surgery (783) Toxicology (107) Transplantation (306) Urology (295)
## Related Clinical Research

- [Why AI for Older Adults Requires Careful Scrutiny, a Geriatrician Warns](https://medichelpline.com/clinical-feed/stat-news-3-stat-a-geriatrician-explains-why-ai-for-older-adults-deserves-careful-scrutiny.md)
- [Increased risk of acute gastroenteritis after COVID-19 hospitalisation: a retrospective England an](https://medichelpline.com/clinical-feed/medrxiv-3-risk-of-acute-gastroenteritis-following-covid-19-exposure-a-retrospective.md)
- [Emergency-granulopoiesis but not CD4/NK trajectory reproducibly correlates with sepsis mortality](https://medichelpline.com/clinical-feed/medrxiv-3-emergency-granulopoiesis-trajectory-but-not-the-cd4-nk-lymphocyte-trajectory-is.md)
- [FDA Rejects Capricor’s Cell Therapy deramiocel for Duchenne Muscular Dystrophy](https://medichelpline.com/clinical-feed/stat-news-0-stat-fda-rejects-capricor-therapeutics-duchenne-therapy-a-decision-that-was-a.md)
- [U.S. POINTER: Structured lifestyle program slows brain aging and cardiometabolic risk over 24 mont](https://medichelpline.com/clinical-feed/medical-news-today-0-combining-physical-mental-and-social-habits-slows-brain-aging-in-2-year-trial.md)

## Navigation
- [← Back to Neurology Feed](https://medichelpline.com/clinical-feed/neurology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.